Form 8-K - Current report:
SEC Accession No. 0001188112-06-001631
Filing Date
2006-05-23
Accepted
2006-05-23 14:30:23
Documents
3
Period of Report
2006-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K t10414_8k.htm 8-K 35511
2 EXHIBIT 17.1 ex17-1.htm EX-17.1 5489
3 EXHIBIT 17.2 ex17-2.htm EX-17.2 7407
  Complete submission text file 0001188112-06-001631.txt   50310
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

EIN.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14339 | Film No.: 06861103
SIC: 3825 Instruments For Meas & Testing of Electricity & Elec Signals